© Copyright Our Wall
Bioinformatics Services Market Research, 2027
The bioinformatics services market is projected to reach USD 5.3 Billion by 2026 from USD 2.5 Billion in 2021, at a CAGR of 15.8% during the forecast period. Growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the bioinformatics services market during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75889439
Bioinformatics is an interdisciplinary field that combines biology, computer science, and data analysis to manage and analyze biological data, particularly DNA, RNA, and protein sequences.
Key Market Players
Bioinformatics Services Market is dominated by Thermo Fisher Scientific (US), Eurofins Scientific (Luxembourg), NeoGenomics (US), Illumina (US) and PerkinElmer (US).
Thermo Fisher Scientific (US) holds the leading position in the global bioinformatics services market. The strong geographic presence across major markets is supporting the growth of the company’s market share. The company primarily focuses on developing technologically advanced bioinformatics solutions to enhance its bioinformatics service offerings.
Eurofins Scientific held the second-largest share of the bioinformatics services market in 2020. It has maintained its position in the global bioinformatics services market due to its wide geographic presence and a broad range of bioinformatics services. The acquisition of GATC Biotech (Germany) further strengthened its service offerings and position in the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=75889439
Key components and services within the bioinformatics services market include:
Sequence Analysis: This involves the analysis of DNA, RNA, and protein sequences, including tasks such as sequence alignment, assembly, and annotation.
Structural Bioinformatics: This area focuses on the prediction of protein structures, including 3D modeling, molecular docking, and structural alignment.
Functional Genomics: Functional genomics studies aim to understand the functions of genes and how they interact within biological systems.
Comparative Genomics: Comparative genomics involves comparing the genomes of different species to identify similarities and differences.
Metagenomics: Metagenomics services analyze genetic material directly from environmental samples, such as soil or water, to study microbial communities.
Data Management and Integration: Managing and integrating diverse biological datasets is a critical service. It includes data storage, retrieval, and integration into bioinformatics workflows.
Software and Tool Development: Many bioinformatics tools and software packages are developed to perform specific analyses. Service providers may develop custom software or adapt existing tools for clients' needs.
Consulting and Training: Bioinformatics service providers often offer consulting services to help researchers design experiments, choose appropriate analysis methods, and interpret results.
Data Visualization: Visualization tools and services help researchers to present their data in a comprehensible manner, aiding in data interpretation and communication of findings.
North America dominated the global bioinformatics services market
The North American market dominated the market. The growth in North America can be attributed to government initiatives for the reimbursement of genomic testing and favorable funding scenario for research activities.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=75889439
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish MehraMarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Esoteric Testing Market Research, 2026
The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708
Esoteric tests are typically not part of routine medical screenings and are ordered by healthcare providers when more detailed and specific information is needed to diagnose or manage a particular medical condition.
Key Market Players:
The global esoteric testing market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US).
Labcorp (US) is one of the leading players in the esoteric testing market. Labcorp Diagnostics (Dx) is the diagnostic business segment of the company that operates through a network of rapid response laboratories, specialty laboratories, primary laboratories, patient service centers, and branches.
Quest Diagnostics (US) is one of the leading players in the esoteric testing market. The leading position can be attributed to its extensive esoteric test portfolio in this market. The company holds a strong foothold in the North America.
OPKO Health Inc. (US) held the third position in the esoteric testing market. The company holds the leading position with its strong geographical presence in the US, Ireland, Spain, Chile and other.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=76794708
Esoteric tests are often characterized by the following features:
Complexity: Esoteric tests are typically more complex and specialized than routine laboratory tests. They may involve advanced techniques and technologies, such as molecular diagnostics, genetic testing, flow cytometry, mass spectrometry, and specialized immunoassays.
Specialized Expertise: Interpreting the results of esoteric tests often requires specialized medical expertise because the results can be intricate and require a deep understanding of the underlying science.
Targeted Applications: Esoteric tests are often used in the diagnosis and monitoring of rare or complex medical conditions, as well as for personalized medicine approaches, cancer diagnostics, and genetic disorders.
North America is the largest regional market for the Esoteric Testing Market
North America was the largest regional market for market. The large share of the North American market can be attributed to the increasing per capita healthcare expenditure, presence of the leading market players, increasing use of rapid diagnostics, expanding geriatric population, and advancing precision medicine in the region.
Esoteric Testing Market Dynamics:
Drivers:
Restraints:
Opportunities:
Make an Enquire to Buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=76794708
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Infectious Disease Diagnostics Market Research, 2027
The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Growth in the infectious disease diagnostics industry is mainly driven by factors such as the rising prevalence of infectious diseases and the rising funding for R&D in infectious disease diagnostics.
To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589
The infectious disease diagnostics market refers to the industry involved in the development, manufacturing, and distribution of diagnostic tests and tools for detecting infectious diseases in humans and animals. Infectious disease diagnostics are critical for the early identification and management of infectious diseases, as they enable healthcare professionals to diagnose and treat infections promptly, prevent the spread of diseases, and track disease outbreaks.
Key components of the infectious disease diagnostics market include:
Diagnostic Tests: These are laboratory or point-of-care tests used to detect the presence of infectious agents, such as bacteria, viruses, fungi, and parasites, in patient samples like blood, urine, or swabs.
Instruments and Equipment: Laboratories and healthcare facilities use specialized instruments and equipment for processing and analyzing diagnostic samples.
Reagents and Consumables: Reagents, test kits, and other consumables are essential for performing diagnostic tests accurately.
Software and Information Systems: Information management systems and software help healthcare professionals track and manage infectious disease data, which is crucial for monitoring and responding to outbreaks.
Services: Companies in the infectious disease diagnostics market often provide services such as test validation, training, technical support, and maintenance to healthcare facilities.
Point-of-Care Testing (POCT): POCT refers to diagnostic tests performed near the patient, often at the bedside or in clinics, providing rapid results.
Telemedicine and Remote Monitoring: In recent years, telemedicine and remote monitoring have gained importance, allowing patients to consult with healthcare providers and share diagnostic data remotely, especially during the COVID-19 pandemic.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589
Key Market Players:
The major players in this market are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics Holdings plc (US), Quidel Corporation (US), Meridian Bioscience (US), Genetic Signatures Ltd. (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems (US), Seegene, Inc. (South Korea), Co-Diagnostics (US), ELITechGroup (France), Epitope Diagnostics (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International (US), Vela Diagnostics (Singapore) and Uniogen Oy (Finland).
Abbott Laboratories accounted for the largest share of the infectious disease diagnostics market. Abbott Laboratories is a leading player in the infectious disease diagnostics market. The launch of the ID NOW POC testing system by the company is expected to support the growth of its infectious disease diagnostics segment.
Thermo Fisher Scientific accounted for the third largest share of the infectious disease diagnostics market. It is one of the key players operating in the infectious disease diagnostics market. The company’s leading position in this market can be attributed to its strong sales and distribution network, enabling it to effectively market its products in various countries.
North America is the largest regional market for infectious disease diagnostics market
North America accounted for the largest share of the market. The large share of this region can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.
Contact us for Special Discount and Pricing @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=116764589
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
The
synthetic biology market is projected to reach USD 35.7 billion by 2027 from
USD 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period. The
growth of this market is mainly driven by rise in demand for synthetic genes
and synthetic cells, declining cost of DNA sequencing and synthesizing.
To know
about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889
Synthetic
biology is an interdisciplinary field that combines principles from biology,
engineering, and computer science to design and construct new biological parts,
devices, and systems, as well as to redesign existing biological systems for
useful purposes.
Key
components and segments of the synthetic biology market include:
Tools and
Technologies: Companies
in this segment develop and sell the tools and technologies necessary for
synthetic biology research and applications. This includes DNA synthesis and
sequencing, genome editing technologies like CRISPR/Cas9, and automation
equipment.
Bioinformatics
and Software: The
field relies heavily on computational tools and software for designing and
simulating biological systems. This segment includes companies that provide
bioinformatics solutions for data analysis and modeling.
Applications:
Synthetic
biology has a wide range of applications, including healthcare (such as the
development of engineered microbes for drug production), agriculture (creating
genetically modified crops), and industrial processes (biofuel production,
specialty chemical synthesis).
Startups
and Biotech Companies: Many startups and biotechnology companies are
actively engaged in synthetic biology research and development.
Academic
and Research Institutions: Universities and research institutions play a
significant role in advancing synthetic biology through fundamental research
and education.
Regulatory
Environment: Given
the potential implications of synthetic biology, regulatory bodies like the
U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA)
have been developing guidelines to ensure safety and ethical considerations are
addressed.
Browse
Complete Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
Key
Market Players
The
prominent players operating in the synthetic biology market are Thermo Fisher
Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US),
Novozymes A/S (Denmark), and Ginkgo Bioworks (US).
Thermo
Fisher Scientific (US) is one of the leading player in synthetic
biology market. The company’s leading position attributable to its diversified
product portfolio, strong geographic presence, and adoption of organic and
inorganic growth strategies. The company has adopted different growth
strategies, such as new product launches and deals that include agreements,
partnerships, acquisitions, and expansions, to maintain its leading position in
the synthetic biology market.
Merck KGaA
(Germany) is
one of the leading players in the life sciences market. The company, through
its acquisition of Sigma-Aldrich (US) in November 2015, entered the synthetic
biology market. The life sciences division of Sigma offers oligonucleotides,
CRISPR genome editing reagents, custom-engineered cell lines, and metabolic
assays in the synthetic biology market. The strength of Sigma-Aldrich lies in
its global reach. The company has its footprint in 37 countries and manages to
reach its customers through its eCommerce platform.
Asia Pacific
is likely to grow at higher double digit during the forecast period.
The Asia
Pacific region is estimated to grow at the highest CAGR in the synthetic
biology market during the forecast period, this is mainly due to factors such
the increasing investment in research & development, emergence of new
market players in synthetic biology market.
Synthetic
Biology Market Dynamics:
Drivers:
·
Diverse applications of synthetic biology
·
Increased funding for research in synthetic
biology
·
Declining cost of DNA sequencing and
synthesizing
·
Innovations in synthetic biology
Restraints:
·
Biosafety, biosecurity, and ethical concerns
Opportunities:
·
Increasing demand for fuel alternatives
·
Growth in research on synthetic drugs and
vaccines
·
Use of machine learning in research and
development
Challenges:
·
Standardization of biological parts
Complete The
Payment and Get the Full Access of Report@ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=889
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best
management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and
program management, leveraging a man-machine offering to drive supernormal
growth for progressive organizations in the B2B space. We have the widest lens
on emerging technologies, making us proficient in co-creating supernormal
growth for clients.
Earlier this year, we made a formal transformation into one of America's
best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new
revenue streams that are substituting existing revenue streams in this decade
alone. We work with clients on growth programs, helping them monetize this $25
trillion opportunity through our service lines - TAM Expansion, Go-to-Market
(GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global
2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our
insights and strategies are molded by our industry experts, cutting-edge
AI-powered Market Intelligence Cloud, and years of research. The
KnowledgeStore™ (our Market Intelligence Cloud) integrates our research,
facilitates an analysis of interconnections through a set of applications,
helping clients look at the entire ecosystem and understand the revenue shifts
happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on
Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Vascular Closure Devices Market Research, 2026
The global vascular closure devices market is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period. The growth in this market can be attributed to a large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries.
To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468
Browse in-depth TOC on "Vascular Closure Devices Market"
151 – Tables
31 – Figures
183 – Pages
Emerging markets providing growth opportunities for market players and growth in the number of hospitals & surgical centers are expected to offer strong growth opportunities for players in the market. In contrast, the need for highly skilled professionals, risks associated with vascular closure devices and stringent regulatory framework may challenge market growth to a certain extent. The vascular closure devices market is segmented based on type, access, procedure, and region.
Vascular closure devices (VCDs) are medical devices used to achieve hemostasis (the stopping of bleeding) at the puncture site after catheterization procedures, such as angiography and percutaneous coronary intervention (PCI). These devices are designed to reduce the time it takes for patients to recover after these procedures and minimize the risk of complications associated with prolonged bleeding.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=180101468
Key Market Players
The prominent players operating in this market include The global vascular closure devices market is consolidated. The top five companies in this market are Terumo Corporation (Japan), Abbott (US), Cardinal Health (US), Cardiva Medical, Inc. (US), Medtronic Plc (Ireland), Morris Innovative, Inc. (US), Teleflex Incorporated (US), Merit Medical Systems, Inc. (US), Vasorum Ltd. (Ireland), TZ Medical, Inc. (US), Vivasure Medical Ltd. (Ireland), Tricol Biomedical (US), Scion Biomedical (US), Advanced Vascular Dynamics (US), Marine Polymer Technologies, Inc. (US), and Rex Medical (US).
Terumo Corporation (Japan) is a leading player in the vascular closure devices market, with a market share of 33.4% . The company’s large share can be attributed to its broad range of vascular closure devices. The company has two distribution channels—direct to customers (healthcare professionals and/or facilities) and sales through distributors.
Abbott (US) accounted for the high share of the vascular closure devices market. The company’s portfolio of vascular closure devices consists of suture-based devices, clip-based devices, and compression assist devices.
Cardinal Health (US) held the third position in the vascular closure devices market in 2020. This can be attributed to its strong brand recognition and comprehensive suite of vascular closure devices, such as MYNX Control, MYNX Grip, EXOSEAL, and Zephyr. A majority of the company’s sales are generated from the US, and only 3% of the sales are generated outside the US. The company could focus on emerging markets for future growth.
North America was the largest regional market for the vascular closure devices market
North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.
Directly Purchase a copy of the report [183] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=180101468
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Drug Screening Market Research, 2026
The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period. Growth in this market is attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
Browse in-depth TOC on "Drug Screening Market"
228 – Tables
36 – Figures
223 – Pages
The drug screening market refers to the industry involved in the development and deployment of various methods and technologies for detecting the presence of drugs or their metabolites in biological samples, such as urine, blood, saliva, or hair.
Drug screening is primarily used in several contexts, including:
Workplace Drug Testing: Many employers require their employees to undergo drug screening as part of pre-employment checks or random testing to ensure a safe and drug-free work environment.
Sports and Athletics: Athletes in competitive sports often undergo drug testing to prevent the use of performance-enhancing substances that could give them an unfair advantage.
Criminal Justice: Drug screening is used in the criminal justice system to monitor individuals on probation or parole, as well as in correctional facilities.
Clinical and Healthcare: Healthcare providers may use drug screening to monitor patients prescribed with controlled substances and to diagnose and treat substance use disorders.
Drug Development: Pharmaceutical companies and research organizations use drug screening to test the efficacy and safety of new drugs in preclinical and clinical trials.
Browse Complete Report @ https://www.marketsandmarkets.com/Market-Reports/drug-alcohol-screening-market-162987773.html
Key Market Players
The drug screening market is highly competitive and populated by several big and small players. Prominent players offering drug screening products and services include LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan), LifeLoc Technologies (US), Drägerwerk (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics (US), Clinical Reference Laboratory (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Synens (France), Intoximeters (US), AccuSource (US), Cordant Health Solutions (US), Millennium Health (US).
LabCorp (US): LabCorp is a leading player in the US drug screening services market. The company’s leading position is attributed to its wide drug testing portfolio, including over 4,800 tests. The company has a strong brand name and robust service portfolio, which provides drug screening services to managed care organizations, governmental agencies, healthcare providers, hospitals and health systems, employers, patients, consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories.
Abbott Laboratories (US): Abbott Laboratories has a strong product portfolio, and its FDA and CE Mark-approved products have helped the company enhance its presence in the drug screening market. Abbott provides abuse testing products and services for many settings such as hospitals, physician offices, criminal justice agencies, workplaces, rehabilitation centers, occupational health clinics, and homes.
North America is expected to dominate the market with a share of 48.2%, followed by Europe.
The large share of this geographical segment is attributed to factors such as growing consumption of illicit drugs, the availability of government funding to curb drug abuse, laws supporting drug screening, the growing burden of accidents due to alcohol impairment, and the presence of key players in the region are driving the growth of the drug screening market in this region.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162987773
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Patient Monitoring Devices Market Research, 2027
The patient
monitoring devices market is projected to reach USD 65.4 billion by 2027
from USD 42.3 billion in 2022, at a CAGR of 9.1% during the forecast period.
The development in this market is largely driven by increased funding, research
grants, and public-private investments; ongoing technological developments in
the field of wearable technologies; sustained government initiatives to expand
healthcare infrastructure in major & emerging markets, and the emergence of
user-centric patient monitoring devices.
Browse in-depth TOC on “Patient Monitoring Devices Market”
349 – Tables
41 – Figures
391 – Pages
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=678
Patient monitoring devices are medical devices used to track
and record various vital signs and physiological parameters of patients in
healthcare settings. These devices play a crucial role in monitoring the health
status of patients, especially those in critical care, post-surgery recovery,
or with chronic illnesses.
Here are some key points and trends related to the
patient monitoring devices market:
Technological Advancements: Advances in technology,
particularly in wireless and remote monitoring, have been driving innovation in
patient monitoring devices.
Remote Monitoring: The COVID-19 pandemic further
accelerated the adoption of remote patient monitoring (RPM) solutions.
Healthcare providers began using remote monitoring to keep track of patients'
vital signs and conditions while minimizing in-person contact.
Home Healthcare: Patient monitoring devices have
increasingly moved into the home healthcare market. Patients with chronic
conditions can use these devices to monitor their health at home, reducing the
need for frequent hospital visits.
Integration with Electronic Health Records (EHRs):
Many patient monitoring devices now offer integration with electronic health
records, making it easier for healthcare providers to access and analyze
patient data.
Types of Monitoring Devices: The patient monitoring
devices market includes a wide range of devices, including blood pressure
monitors, pulse oximeters, electrocardiography (ECG) devices, glucose monitors,
and more.
Read Full Report with Table of Contents @ https://www.marketsandmarkets.com/Market-Reports/patient-healthcare-monitoring-systems-devices-market-678.html
Key
Market Players
The patient monitoring devices market was dominated by GE
Healthcare (US), Medtronic plc (Ireland), Abbott Laboratories (US), Koninklijke
Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), and Masimo
Corporation (US).
Medtronic plc (US) has a broad range of product
offerings in the patient monitoring devices market. Their relevant product
portfolio includes respiratory monitoring devices, neuromonitoring, heart
monitoring devices, and blood glucose monitoring devices. The company is
focused on innovations and improving the quality of its products with
increasing investment in its R&D department.
GE Healthcare (US) is among the leading players in
the global patient monitoring devices market. GE Healthcare is a pioneer of
innovative solutions for patient monitoring devices in various fields such as
cardiac monitoring devices, multi-parameter monitoring devices, and neonatal
and fetal monitoring products.
North America is likely to lead the global patient
monitoring devices market
North America, encompassing the US and Canada, reported for
the major split of the patient monitoring devices market. An growing quantity
of clinical trials verifying patient monitoring devices and a rising amount of
approvals for patient monitoring. Are the major factors driving market growth
in North America. Customers in North America are shifting towards homecare
patient monitoring, that requires non-invasive patient monitoring devices. This
trend will have a definite impact on the patient monitoring device market.
Contact us
for Special Discount and Pricing @: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=678
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine offering to drive
supernormal growth for progressive organizations in the B2B space. We have the
widest lens on emerging technologies, making us proficient in co-creating
supernormal growth for clients.
Earlier this year, we made a formal transformation into one
of America's best management consulting firms as per a survey conducted by
Forbes.
The B2B economy is witnessing the emergence of $25 trillion
of new revenue streams that are substituting existing revenue streams in this
decade alone. We work with clients on growth programs, helping them monetize
this $25 trillion opportunity through our service lines - TAM Expansion,
Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account
Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive
ecosystem. Our insights and strategies are molded by our industry experts,
cutting-edge AI-powered Market Intelligence Cloud, and years of research. The
KnowledgeStore™ (our Market Intelligence Cloud) integrates our research,
facilitates an analysis of interconnections through a set of applications,
helping clients look at the entire ecosystem and understand the revenue shifts
happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]